Vimarsana
Biggest News Aggregation in the World

Page 4 - Cipher Pharmaceuticals News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cipher Pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cipher Pharmaceuticals Today - Breaking & Trending Today

Cipher Pharmaceuticals (TSE:CPH) Reaches New 1-Year High at $6.35 - Vimarsana News

Cipher Pharmaceuticals (TSE:CPH) Reaches New 1-Year High at $6.35

Cipher Pharmaceuticals Inc. (TSE:CPH – Get Free Report) (NASDAQ:CPHR)’s stock price reached a new 52-week high during trading on Monday . The company traded as high as C$6.35 and last traded at C$6.23, with a volume of 39301 shares changing hands. The stock had previously closed at C$6.22. Cipher Pharmaceuticals Trading Up 0.6 % The […]

Cipher Pharmaceuticals (TSE:CPH) Hits New 12-Month High at $6.35 - Vimarsana News

Cipher Pharmaceuticals (TSE:CPH) Hits New 12-Month High at $6.35

Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.

Cipher Pharmaceuticals Inc.'s (TSE:CPH) 23% gain last week benefited both individual investors who own 56% as well as insiders - Vimarsana News

Cipher Pharmaceuticals Inc.'s (TSE:CPH) 23% gain last week benefited both individual investors who own 56% as well as insiders

Key Insights Cipher Pharmaceuticals' significant individual investors ownership suggests that the key decisions are...

Source: yahoo.com
Cipher Pharmaceuticals Inc. (OTCMKTS:CPHRF) Sees Significant Increase in Short Interest - Vimarsana News

Cipher Pharmaceuticals Inc. (OTCMKTS:CPHRF) Sees Significant Increase in Short Interest

Cipher Pharmaceuticals Inc. (OTCMKTS:CPHRF – Get Free Report) (TSE:CPH) was the target of a significant increase in short interest during the month of October. As of October 31st, there was short interest totalling 5,500 shares, an increase of 223.5% from the October 15th total of 1,700 shares. Based on an average daily volume of 7,300 […]

Actinic Keratosis Treatment Industry's Impressive CAGR of 7.0% Enroot to US$ 8.0 Billion by 2028 | FMI - Vimarsana News

Actinic Keratosis Treatment Industry's Impressive CAGR of 7.0% Enroot to US$ 8.0 Billion by 2028 | FMI

The global Actinic Keratosis Treatment Industry is on an impressive growth trajectory, according to the latest report by Future Market Insights (FMI). In 2022, the market was valued at approximately US$ 5.4 billion, and it is projected to reach an astounding US$ 8.0 billion by 2028, with an expected compound annual...